These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 19903895)
21. Formation and function of tissue-resident memory T cells during viral infection. Shin H Curr Opin Virol; 2018 Feb; 28():61-67. PubMed ID: 29175730 [TBL] [Abstract][Full Text] [Related]
22. Blood and beyond: properties of circulating and tissue-resident human virus-specific αβ CD8(+) T cells. van Aalderen MC; Remmerswaal EB; ten Berge IJ; van Lier RA Eur J Immunol; 2014 Apr; 44(4):934-44. PubMed ID: 24448915 [TBL] [Abstract][Full Text] [Related]
23. Simultaneous approach using systemic, mucosal and transcutaneous routes of immunization for development of protective HIV-1 vaccines. Belyakov IM; Ahlers JD Curr Med Chem; 2011; 18(26):3953-62. PubMed ID: 21824096 [TBL] [Abstract][Full Text] [Related]
25. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Miller JD; van der Most RG; Akondy RS; Glidewell JT; Albott S; Masopust D; Murali-Krishna K; Mahar PL; Edupuganti S; Lalor S; Germon S; Del Rio C; Mulligan MJ; Staprans SI; Altman JD; Feinberg MB; Ahmed R Immunity; 2008 May; 28(5):710-22. PubMed ID: 18468462 [TBL] [Abstract][Full Text] [Related]
26. Memory cytolytic T-lymphocytes: induction, regulation and implications for vaccine design. Baz A; Jackson DC; Kienzle N; Kelso A Expert Rev Vaccines; 2005 Oct; 4(5):711-23. PubMed ID: 16221072 [TBL] [Abstract][Full Text] [Related]
32. Targeting of non-dominant antigens as a vaccine strategy to broaden T-cell responses during chronic viral infection. Holst PJ; Jensen BA; Ragonnaud E; Thomsen AR; Christensen JP PLoS One; 2015; 10(2):e0117242. PubMed ID: 25679375 [TBL] [Abstract][Full Text] [Related]
33. Bone marrow of persistently hepatitis C virus-infected individuals accumulates memory CD8+ T cells specific for current and historical viral antigens: a study in patients with benign hematological disorders. Racanelli V; Frassanito MA; Leone P; Brunetti C; Ruggieri S; Dammacco F J Immunol; 2007 Oct; 179(8):5387-98. PubMed ID: 17911625 [TBL] [Abstract][Full Text] [Related]
34. Memory CD8(+) T cells elicited by HIV-1 lipopeptide vaccines display similar phenotypic profiles but differences in term of magnitude and multifunctionality compared with FLU- or EBV-specific memory T cells in humans. Figueiredo S; Charmeteau B; Surenaud M; Salmon D; Launay O; Guillet JG; Hosmalin A; Gahery H Vaccine; 2014 Jan; 32(4):492-501. PubMed ID: 24291199 [TBL] [Abstract][Full Text] [Related]
35. Reduced functional avidity promotes central and effector memory CD4 T cell responses to tumor-associated antigens. Caserta S; Kleczkowska J; Mondino A; Zamoyska R J Immunol; 2010 Dec; 185(11):6545-54. PubMed ID: 21048115 [TBL] [Abstract][Full Text] [Related]
37. Novel HIV IL-4R antagonist vaccine strategy can induce both high avidity CD8 T and B cell immunity with greater protective efficacy. Jackson RJ; Worley M; Trivedi S; Ranasinghe C Vaccine; 2014 Sep; 32(43):5703-14. PubMed ID: 25151041 [TBL] [Abstract][Full Text] [Related]
38. Making memories that last a lifetime: heritable functions of self-renewing memory CD8 T cells. Youngblood B; Davis CW; Ahmed R Int Immunol; 2010 Oct; 22(10):797-803. PubMed ID: 20732857 [TBL] [Abstract][Full Text] [Related]
39. Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections. Panagioti E; Klenerman P; Lee LN; van der Burg SH; Arens R Front Immunol; 2018; 9():276. PubMed ID: 29503649 [TBL] [Abstract][Full Text] [Related]
40. Novel peptide-based vaccines efficiently prime murine "help"-independent CD8+ T cell responses in the liver. Dikopoulos N; Riedl P; Schirmbeck R; Reimann J Hepatology; 2004 Aug; 40(2):300-9. PubMed ID: 15368434 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]